Policy & Regulation
Kwivik Therapeutics forms EirMed partnership
14 January 2021 -

United States-based Kwivik Therapeutics Inc, a medtech platform company, has collaborated with United States-based EirMed to expedite commercialisation of certain therapeutics product lines, it was reported on Wednesday.

Under the collaboration, EirMed will be responsible for a large number of Kwivik's custom moulded components and various secondary processes. Kwivik Therapeutics Inc has invested and produced all of its own tooling situated at EirMed.

Julian Ross, CEO of Kwivik Therapeutics, said, 'We are excited to be working with EirMed as we enter a growth phase in our business. EirMed is a fine organisation and will significantly expand our capacity and depth with their infrastructure, design, engineering, manufacturing, quality control, and regulatory compliance capabilities.'



Related Headlines